Covidien (NYSE: COV ) shares are up more than 20% today on stellar news that dividend aristocrat Medtronic (NYSE: MDT ) is moving in to acquire the medical device maker for $42.9 billion. Inevitably, there is a lot of information in the press release -- so let's condense it down to three quick things you need to know.
In the video below, health care analyst Michael Douglass lays out the three quick facts about the proposed Covidien-Medtronic deal that immediately piqued his interest, and why the price looks like an exciting deal for Covidien shareholders.
Leaked: A huge small-cap opportunity
This smart device –kept secret until now – could mark a new revolution in smart tech (with big implications for health care). It's a gigantic market opportunity -- ABI Research predicts 485 million of its type will be sold per year. To learn about the small-cap stock making this device possible – the stock that could mint millionaires left and right when its full market potential is realized – click here.